These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21772817)

  • 1. Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons.
    Ledonne A; Berretta N; Davoli A; Rizzo GR; Bernardi G; Mercuri NB
    Front Syst Neurosci; 2011; 5():56. PubMed ID: 21772817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.
    Ledonne A; Federici M; Giustizieri M; Pessia M; Imbrici P; Millan MJ; Bernardi G; Mercuri NB
    Br J Pharmacol; 2010 Jul; 160(6):1509-20. PubMed ID: 20590640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord.
    Gozal EA; O'Neill BE; Sawchuk MA; Zhu H; Halder M; Chou CC; Hochman S
    Front Neural Circuits; 2014; 8():134. PubMed ID: 25426030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
    Pei Y; Asif-Malik A; Canales JJ
    Front Neurosci; 2016; 10():148. PubMed ID: 27092049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system.
    Khan MZ; Nawaz W
    Biomed Pharmacother; 2016 Oct; 83():439-449. PubMed ID: 27424325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons.
    Geracitano R; Federici M; Prisco S; Bernardi G; Mercuri NB
    Neuropharmacology; 2004 May; 46(6):807-14. PubMed ID: 15033340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A renaissance in trace amines inspired by a novel GPCR family.
    Lindemann L; Hoener MC
    Trends Pharmacol Sci; 2005 May; 26(5):274-81. PubMed ID: 15860375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of trace amines and their receptors for treating neurological and psychiatric diseases.
    Berry MD
    Rev Recent Clin Trials; 2007 Jan; 2(1):3-19. PubMed ID: 18473983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primate trace amine receptor 1 modulation by the dopamine transporter.
    Miller GM; Verrico CD; Jassen A; Konar M; Yang H; Panas H; Bahn M; Johnson R; Madras BK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):983-94. PubMed ID: 15764732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico and in Vitro Study of Trace Amines (TA) and Dopamine (DOP) Interaction with Human Alpha 1-Adrenergic Receptor and the Bacterial Adrenergic Receptor QseC.
    Luqman A; Kharisma VD; Ruiz RA; Götz F
    Cell Physiol Biochem; 2020 Sep; 54(5):888-898. PubMed ID: 32930525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels.
    Federici M; Geracitano R; Tozzi A; Longone P; Di Angelantonio S; Bengtson CP; Bernardi G; Mercuri NB
    Mol Pharmacol; 2005 Apr; 67(4):1283-90. PubMed ID: 15644497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localization and functions of the D-neuron: significance in pathogenesis of schizophrenia].
    Ikemoto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):141-7. PubMed ID: 25069249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics-based simulation of trace amine membrane permeability.
    Berry MD; Nickel J; Shitut MR; Tomberli B
    J Neural Transm (Vienna); 2011 Jul; 118(7):1119-28. PubMed ID: 21210285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace amine-associated receptors as emerging therapeutic targets.
    Sotnikova TD; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2009 Aug; 76(2):229-35. PubMed ID: 19389919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.
    Berry MD
    J Neurochem; 2004 Jul; 90(2):257-71. PubMed ID: 15228583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
    Burchett SA; Hicks TP
    Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.
    Halff EF; Rutigliano G; Garcia-Hidalgo A; Howes OD
    Trends Neurosci; 2023 Jan; 46(1):60-74. PubMed ID: 36369028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.